Lv3
238 积分 2023-10-10 加入
Engineering IL-2 for immunotherapy of autoimmunity and cancer
17小时前
待确认
DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell–mediated antitumor immunity
9天前
已完结
Inhibition mechanism of MRTX1133 on KRASG12D: a molecular dynamics simulation and Markov state model study
13天前
已完结
Transferrin Receptor Targeting Chimeras (TransTACs) for Membrane Protein Degradation
19天前
已关闭
i-shaped antibodies achieve receptor agonism
20天前
已完结
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
20天前
已完结
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
21天前
已完结
Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review
21天前
已完结
MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
21天前
已完结
Nek7 kinase targeting leads to early mortality, cytokinesis disturbance and polyploidy
26天前
已完结
皖公网安备34019202002308
